| Study samples | Prevalence in population$ |  | |||
---|---|---|---|---|---|---|
 | Control area | SMC area | Control area | SMC area | Prevalence ratio^ | p-value |
 |  |  |  |  | SMC/ non SMC (95% CI) |  |
Prevalence of parasitaemia: | 66/1686 | 18/1019 | 4.86 | 1.46 | 0.30 (0.15, 0.61) | 0.001 |
Prevalence of mutations | Â | Â | Â | Â | Â | Â |
dhfr triple (51, 59, 108) | 27/37 | 7/8 | 2.88 | 1.55 | 0.54 (0.25, 1.17) | 0.12 |
dhps-437 | 25/37 | 7/8 | 2.68 | 1.55 | 0.58 (0.25, 1.34) | 0.20 |
SP resistant mutant (dhfr triple + dhps 437) | 23/37 | 6/8 | 2.47 | 1.32 | 0.54 (0.22, 1.30) | 0.17 |
crt CVIET mutation | 8/35 | 2/3 | 0.87 | 1.18 | 1.36 (0.39, 4.71) | 0.63 |
mdr 86Y | 0/19 | 1/5 | 0 | 0.35 | - | - |
mdr 184F | 13/19 | 4/5 | 2.74 | 1.41 | 0.52 (0.23, 1.14) | 0.10 |
AQ resistant mutant (mdr 86Y + crt CVIET) | 0/13 | 1/2 | 0 | 0.88 | - | - |
SP resistant & AQ resistant | 0/11 | 1/2 | 0 | 0.88 | - | - |